ES2177084T3 - Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso. - Google Patents
Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso.Info
- Publication number
- ES2177084T3 ES2177084T3 ES98955701T ES98955701T ES2177084T3 ES 2177084 T3 ES2177084 T3 ES 2177084T3 ES 98955701 T ES98955701 T ES 98955701T ES 98955701 T ES98955701 T ES 98955701T ES 2177084 T3 ES2177084 T3 ES 2177084T3
- Authority
- ES
- Spain
- Prior art keywords
- sulfinyl
- benzohidrile
- somnolence
- treat
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000032140 Sleepiness Diseases 0.000 title 1
- 206010041349 Somnolence Diseases 0.000 title 1
- XTQHKBHJIVJGKJ-UHFFFAOYSA-N sulfur monoxide Chemical class S=O XTQHKBHJIVJGKJ-UHFFFAOYSA-N 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- -1 methylene dioxy Chemical group 0.000 abstract 1
- 229960005181 morphine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Uso, para la fabricación de medicamentos con efecto estimulante en situaciones de alteraciones de la vigilancia relacionadas con un tratamiento morfínico, compuestos de benzohidrilo sulfinilo que responden a la fórmula general (I), CH-SO-(CH2)4-CO-NHR en la que, cada uno de los ciclos puede ser sustituido por uno o más grupos F, Cl, Br, CF3, NO2, NH2, alkilo en C1-C4, alkoxi en C1-C4, metilenodioxi; R representa un grupo hidróxilo, un átomo de hidrógeno, un grupo alkilo en C1-C4, un grupo hidroxialkilo en C1- C4, n es un entero igual a 1, 2 ó 3; y sus sales de adición cuando R incluye un resto básico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9714519A FR2771004B1 (fr) | 1997-11-19 | 1997-11-19 | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2177084T3 true ES2177084T3 (es) | 2002-12-01 |
Family
ID=9513542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98955701T Expired - Lifetime ES2177084T3 (es) | 1997-11-19 | 1998-11-19 | Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6566404B2 (es) |
| EP (1) | EP1032376B1 (es) |
| AT (1) | ATE216879T1 (es) |
| AU (1) | AU743915B2 (es) |
| CA (1) | CA2310141C (es) |
| DE (1) | DE69805202T2 (es) |
| DK (1) | DK1032376T3 (es) |
| ES (1) | ES2177084T3 (es) |
| FR (1) | FR2771004B1 (es) |
| WO (1) | WO1999025329A1 (es) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6346548B1 (en) | 1999-08-16 | 2002-02-12 | Cephalon, Inc. | Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| US6455588B1 (en) | 1999-08-20 | 2002-09-24 | Cephalon, Inc. | Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| FR2804322B1 (fr) * | 2000-01-31 | 2002-04-19 | Lafon Labor | Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies |
| US6670358B2 (en) * | 2000-05-16 | 2003-12-30 | Cephalon, Inc. | Substituted thioacetamides |
| US6492396B2 (en) | 2000-05-16 | 2002-12-10 | Cephalon, Inc. | Substituted thioacetamides |
| ES2277937T3 (es) * | 2000-07-27 | 2007-08-01 | Teva Pharmaceutical Industries Ltd. | Modafinilo puro y cristalino y su procedimiento de preparacion. |
| JP4593074B2 (ja) * | 2000-10-11 | 2010-12-08 | セフアロン・インコーポレーテツド | モダフィニル化合物含有組成物 |
| US6919378B2 (en) | 2000-10-11 | 2005-07-19 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
| US6489363B2 (en) * | 2000-10-11 | 2002-12-03 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
| CA2425338C (en) * | 2000-10-11 | 2010-04-20 | Cephalon, Inc. | Compositions comprising modafinil compounds |
| US6992219B2 (en) | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
| CA2518465A1 (en) | 2003-03-25 | 2004-10-14 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
| AR045314A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Composiciones farmaceuticas de analepticos y antidepresivos |
| AR045423A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Combinaciones de analiticos y antidepresivos |
| US20040229941A1 (en) * | 2003-05-13 | 2004-11-18 | Cephalon, Inc. | Analeptic and antidepressant combinations |
| US20040242698A1 (en) * | 2003-05-13 | 2004-12-02 | Cephalon Inc. | Analeptic and antidepressant combinations |
| US20040229943A1 (en) * | 2003-05-16 | 2004-11-18 | Cephalon Inc | Analeptic and drug combinations |
| KR20060041309A (ko) | 2003-08-13 | 2006-05-11 | 다케다 야쿠힌 고교 가부시키가이샤 | 4-피리미돈 유도체 및 펩티딜 펩티다제 저해제로서의 그의용도 |
| EP1697342A2 (en) * | 2003-09-08 | 2006-09-06 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| EP1699777B1 (en) * | 2003-09-08 | 2012-12-12 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US7368591B2 (en) | 2003-09-19 | 2008-05-06 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
| UA85871C2 (uk) * | 2004-03-15 | 2009-03-10 | Такеда Фармасьютікал Компані Лімітед | Інгібітори дипептидилпептидази |
| US7119214B2 (en) | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| US7449481B2 (en) | 2004-04-13 | 2008-11-11 | Cephalon, Inc. | Thio-substituted biaryl-methanesulfinyl derivatives |
| EP1586560A1 (en) | 2004-04-13 | 2005-10-19 | Cephalon, Inc. | Thio-substituted arylmethanesulfinyl derivatives |
| US7297817B2 (en) | 2004-04-13 | 2007-11-20 | Cephalon France | Thio-substituted arylmethanesulfinyl derivatives |
| US7314875B2 (en) * | 2004-04-13 | 2008-01-01 | Cephalon, Inc. | Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
| MY147393A (en) * | 2005-09-14 | 2012-11-30 | Takeda Pharmaceutical | Administration of dipeptidyl peptidase inhibitors |
| PE20070622A1 (es) * | 2005-09-14 | 2007-08-22 | Takeda Pharmaceutical | Administracion de inhibidores de dipeptidil peptidasa |
| PT1931350E (pt) * | 2005-09-14 | 2014-02-12 | Takeda Pharmaceutical | Administração de inibidores de dipeptidil peptidase |
| TW200745080A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor |
| TW200745079A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| CA2622642C (en) * | 2005-09-16 | 2013-12-31 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| WO2007112368A1 (en) * | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Preparation of (r)-3-aminopiperidine dihydrochloride |
| AU2007272501A1 (en) * | 2006-07-12 | 2008-01-17 | Elan Pharma International Limited | Nanoparticulate formulations of modafinil |
| US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
| MX2009002772A (es) * | 2006-09-13 | 2009-05-28 | Takeda Pharmaceutical | Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro- 2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo. |
| TW200838536A (en) * | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
| FR2987267B1 (fr) | 2012-02-28 | 2015-01-16 | Debregeas Et Associes Pharma | Application du modafinil dans le traitement de substitution des cacainomanes |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1584462A (en) * | 1977-03-31 | 1981-02-11 | Lafon Labor | N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them |
-
1997
- 1997-11-19 FR FR9714519A patent/FR2771004B1/fr not_active Expired - Fee Related
-
1998
- 1998-11-19 AT AT98955701T patent/ATE216879T1/de active
- 1998-11-19 DE DE69805202T patent/DE69805202T2/de not_active Expired - Lifetime
- 1998-11-19 ES ES98955701T patent/ES2177084T3/es not_active Expired - Lifetime
- 1998-11-19 DK DK98955701T patent/DK1032376T3/da active
- 1998-11-19 WO PCT/FR1998/002478 patent/WO1999025329A1/fr not_active Ceased
- 1998-11-19 AU AU12451/99A patent/AU743915B2/en not_active Ceased
- 1998-11-19 CA CA2310141A patent/CA2310141C/fr not_active Expired - Fee Related
- 1998-11-19 EP EP98955701A patent/EP1032376B1/fr not_active Expired - Lifetime
- 1998-11-19 US US09/554,682 patent/US6566404B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20030008925A1 (en) | 2003-01-09 |
| EP1032376A1 (fr) | 2000-09-06 |
| AU1245199A (en) | 1999-06-07 |
| CA2310141A1 (fr) | 1999-05-27 |
| US6566404B2 (en) | 2003-05-20 |
| FR2771004B1 (fr) | 2000-02-18 |
| DE69805202D1 (de) | 2002-06-06 |
| ATE216879T1 (de) | 2002-05-15 |
| EP1032376B1 (fr) | 2002-05-02 |
| CA2310141C (fr) | 2010-04-27 |
| DE69805202T2 (de) | 2002-12-05 |
| FR2771004A1 (fr) | 1999-05-21 |
| AU743915B2 (en) | 2002-02-07 |
| WO1999025329A1 (fr) | 1999-05-27 |
| DK1032376T3 (da) | 2002-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2177084T3 (es) | Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso. | |
| MX9505063A (es) | Tetralina- e indano-1h-imidazoles. | |
| ES2066620T3 (es) | Nuevos derivados de perhidroisoindol y su preparacion. | |
| ES2071510T3 (es) | Derivados de pirrolidina y de tiazolidina, su preparacion y los medicamentos que les contienen. | |
| AR030596A1 (es) | Derivados de quinolina y quinazolina, un procedimiento para su preparacion, composicion farmaceutica que los comprende, uso de los mismos para la elaboracion de medicamentos | |
| HUP0400365A2 (hu) | 3-Fluor-pirrolidinek, mint cukorbetegség elleni szerek és a vegyületeket tartalmazó gyógyszerkészítmények | |
| CO5031241A1 (es) | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos | |
| ES2175161T3 (es) | Derivados de piperazina como antagonistas de taquiquinina. | |
| ECSP055747A (es) | Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos | |
| AR024390A1 (es) | Nuevos compuestos | |
| AR020691A1 (es) | Derivados del acido 2,4-pentadienoico que tienen actividad selectiva para los receptores (rxr) del retinoide x | |
| AR019190A1 (es) | Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos | |
| ES2062610T3 (es) | Compuesto diarilico anti-ateroesclerotico. | |
| CO4700523A1 (es) | Purin-6-onas bisustituidas en 2,9 | |
| AR012603A1 (es) | Inhibidor de proteasa, composicion farmaceutica que lo comprende y el uso del mismo para la fabricacion de un medicamento; e intermediarios de sintesis | |
| AR009572A1 (es) | Derivados de 3,4,5,6,7,8-hexahidro pirido (4',3':4,5) tieno (2,3-d) pirimidina sustituidos en posicion 3 y su uso | |
| CO4810374A1 (es) | Nueva utilizacion de compuestos para actividad anti- pruritica | |
| AR002016A1 (es) | Derivados de 3-fenilisoquinoleina-1-(2h)-ona, procedimiento para su preparacion y medicamento y composicion farmaceutica que los contienen. | |
| DK1086096T3 (da) | Benzamider med tetrahydrofuranyloxy-substituenter som inhibitorer af phosphodiesterase 4 | |
| MX9300433A (es) | Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen. | |
| AR041339A1 (es) | Derivados de tiazolpirimidinona,proceso de preparacion y composiciones farmaceuticas que los contienen | |
| ES488446A1 (es) | Procedimiento para la preparacion de nuevos derivados indo- licos | |
| AR026350A1 (es) | Derivados de isoxazol como inhibidores de la fosfodiesterasa vii | |
| DE60121587D1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
| ES2077998T3 (es) | Derivados de 2-aminopirimidina-4-carboxamida, su preparacion y su aplicacion terapeutica. |